Sleep Disorders Trial, Recruiting NCT05678088 Sponsor: Sunnybrook Health Sciences Centre Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05678088
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with obstructive sleep apnea (OSA), where breathing repeatedly stops or is reduced during sleep, with a severity score of 10 or more events per hour — and where more than half of those events are caused by the airway being blocked (rather than a brain signalling problem)
  • People who are unwilling to use a CPAP machine (a mask and air pressure device for sleep apnea) or have been unable to tolerate it after trying it for at least two weeks
  • People who are not currently using any device-based or surgical treatment for their sleep apnea, such as a CPAP machine, a dental/mouth device, or a nerve stimulation implant

Who may not be able to join:

  • People who are planning to have airway surgery, or to start using a CPAP machine, dental device, or other equipment-based sleep apnea treatment during the study period
  • People whose sleep apnea events are mostly caused by a brain signalling problem (called central sleep apnea), making up 50% or more of their total events
  • People with significant difficulties with thinking or memory, based on a standard cognitive test score below 18
  • People with a significant neurological condition that could affect the muscles in the throat and mouth area
  • People who use medications that relax the upper airway — such as sleeping tablets or opioid pain medicines — on three or more nights per week in the four weeks before the study begins (examples include hypnotics and opiates)
  • People who use a medical device that would interfere with a home sleep apnea test used in the study
  • People who are planning to move to a different city during the study in a way that would affect their ability to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mark Boulos, MD, MSc, Sunnybrook Health Sciences Centre

Phone: 416-480-4473

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 March 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Rate of recruitment; Patient adherence with the study exercises; Ability to ascertain Obstructive Sleep Apnea (OSA) severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov